146 related articles for article (PubMed ID: 9207876)
1. [Genetic alterations associated with pathologic differentiation of Wilms' tumors].
Chevalier G; Perbal B
Bull Cancer; 1997 Mar; 84(3):289-303. PubMed ID: 9207876
[TBL] [Abstract][Full Text] [Related]
2. Contribution of MAV-1-induced nephroblastoma to the study of genes involved in human Wilms' tumor development.
Perbal B
Crit Rev Oncog; 1994; 5(6):589-613. PubMed ID: 8519812
[TBL] [Abstract][Full Text] [Related]
3. Regulation of nov by WT1: a potential role for nov in nephrogenesis.
Martinerie C; Chevalier G; Rauscher FJ; Perbal B
Oncogene; 1996 Apr; 12(7):1479-92. PubMed ID: 8622864
[TBL] [Abstract][Full Text] [Related]
4. novH: differential expression in developing kidney and Wilm's tumors.
Chevalier G; Yeger H; Martinerie C; Laurent M; Alami J; Schofield PN; Perbal B
Am J Pathol; 1998 Jun; 152(6):1563-75. PubMed ID: 9626060
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic potential of myeloblastosis-associated viruses.
Perbal B
Infect Agents Dis; 1995 Dec; 4(4):212-27. PubMed ID: 8665086
[TBL] [Abstract][Full Text] [Related]
6. Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation.
Liu C; Liu XJ; Crowe PD; Kelner GS; Fan J; Barry G; Manu F; Ling N; De Souza EB; Maki RA
Gene; 1999 Oct; 238(2):471-8. PubMed ID: 10570975
[TBL] [Abstract][Full Text] [Related]
7. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas.
Joliot V; Martinerie C; Dambrine G; Plassiart G; Brisac M; Crochet J; Perbal B
Mol Cell Biol; 1992 Jan; 12(1):10-21. PubMed ID: 1309586
[TBL] [Abstract][Full Text] [Related]
8. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
9. Physical mapping of human loci homologous to the chicken nov proto-oncogene.
Martinerie C; Viegas-Pequignot E; Guenard I; Dutrillaux B; Nguyen VC; Bernheim A; Perbal B
Oncogene; 1992 Dec; 7(12):2529-34. PubMed ID: 1334251
[TBL] [Abstract][Full Text] [Related]
10. Deletions within the U3 long terminal repeat alter the tumorigenic potential of myeloblastosis associated virus type 1(N).
Khelifi-Younes C; Dambrine G; Cherel Y; Soubieux D; Li CL; Perbal B
Virology; 2003 Nov; 316(1):84-9. PubMed ID: 14599793
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of novH is associated with human adrenocortical tumorigenesis.
Martinerie C; Gicquel C; Louvel A; Laurent M; Schofield PN; Le Bouc Y
J Clin Endocrinol Metab; 2001 Aug; 86(8):3929-40. PubMed ID: 11502835
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of xnov, a Xenopus laevis ortholog of the chicken nov gene.
Ying Z; King ML
Gene; 1996 Jun; 171(2):243-8. PubMed ID: 8666280
[TBL] [Abstract][Full Text] [Related]
13. Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor.
Gerald WL; Gramling TS; Sens DA; Garvin AJ
Am J Pathol; 1992 May; 140(5):1031-7. PubMed ID: 1316081
[TBL] [Abstract][Full Text] [Related]
14. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
15. Identical genetic changes in different histologic components of Wilms' tumors.
Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
[TBL] [Abstract][Full Text] [Related]
16. [Wilms' tumors and malformation complexes].
Hata J; Fukuzawa R; Takata A; Kikuchi H
Nihon Rinsho; 2000 Jul; 58(7):1419-25. PubMed ID: 10921316
[TBL] [Abstract][Full Text] [Related]
17. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.
Perbal B
Mol Pathol; 2001 Apr; 54(2):57-79. PubMed ID: 11322167
[TBL] [Abstract][Full Text] [Related]
18. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
19. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.
Li CM; Kim CE; Margolin AA; Guo M; Zhu J; Mason JM; Hensle TW; Murty VV; Grundy PE; Fearon ER; D'Agati V; Licht JD; Tycko B
Am J Pathol; 2004 Dec; 165(6):1943-53. PubMed ID: 15579438
[TBL] [Abstract][Full Text] [Related]
20. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
